
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
Emery, P, Keystone, E, Tony, H P, Cantagrel, A, van Vollenhoven, R, Sanchez, A, Alecock, E, Lee, J, Kremer, JVolume:
67
Année:
2007
Langue:
english
Pages:
8
DOI:
10.1136/ard.2008.092932
Fichier:
PDF, 353 KB
english, 2007